A Theranostic Approach for CAR-T Cell Therapy

Wolfgang A Weber1, Zohreh Varasteh1,2, Katja Fritschle1

  • 1Department of Nuclear Medicine, Technical University of Munich, Munich, Germany.

Insights

Fibroblast activation protein (FAP) is a promising target in cancer therapy due to its tumor-specific expression. However, FAP-targeted treatments have yielded limited success, highlighting the need for better patient selection and response monitoring through FAP imaging.

Area of Science:

  • Oncology
  • Molecular Imaging
  • Cancer Biology

Background:

  • Fibroblast activation protein (FAP) is highly expressed in tumor stroma but restricted in normal tissues.
  • FAP's tumor-specific expression makes it an attractive target for cancer therapies.
  • Despite its potential, FAP-targeted therapies have faced challenges in clinical success.

Discussion:

  • FAP imaging presents a novel strategy to overcome limitations in FAP-targeted therapies.
  • Imaging can identify patients who are most likely to benefit from FAP-targeted treatments.
  • Monitoring tumor response to FAP-targeted therapies can be achieved through imaging.

Key Insights:

  • FAP expression is a key biomarker in the tumor microenvironment.
  • Limitations in FAP-targeted therapies necessitate improved patient stratification.
  • FAP imaging offers a solution for patient selection and treatment monitoring.

Outlook:

  • Advancements in FAP imaging could enhance the efficacy of FAP-targeted cancer treatments.
  • FAP imaging may guide personalized medicine approaches in oncology.
  • Further research into FAP imaging applications is crucial for clinical translation.

Related Concept Videos